Apollon Wealth Management LLC Has $1.09 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Apollon Wealth Management LLC lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 17.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 7,463 shares of the financial services provider’s stock after selling 1,539 shares during the quarter. Apollon Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,087,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Highline Wealth Partners LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $36,000. Voisard Asset Management Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $59,000. Finally, Chris Bulman Inc acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $64,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 2.6 %

Shares of IBB stock opened at $140.09 on Friday. iShares Biotechnology ETF has a 52 week low of $116.70 and a 52 week high of $150.57. The firm has a 50 day moving average of $144.68 and a 200-day moving average of $141.56.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.